gentamicin has been researched along with Diabetic Glomerulosclerosis in 4 studies
Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
Excerpt | Relevance | Reference |
---|---|---|
" This paper reports the results of studies concerning carnosine's role in kidney diseases, particularly in ischemia/reperfusion induced acute renal failure, diabetic nephropathy, gentamicin-induced nephrotoxicity and also in blood pressure regulation." | 8.88 | [Carnosine, carnosinase and kidney diseases]. ( Kiliś-Pstrusińska, K, 2012) |
" This paper reports the results of studies concerning carnosine's role in kidney diseases, particularly in ischemia/reperfusion induced acute renal failure, diabetic nephropathy, gentamicin-induced nephrotoxicity and also in blood pressure regulation." | 4.88 | [Carnosine, carnosinase and kidney diseases]. ( Kiliś-Pstrusińska, K, 2012) |
"Thrombosis was defined as the inability to use catheter at a blood flow of 200 ml/min despite intraluminal thrombolysis." | 2.72 | Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placement. ( Abu-Oun, BA; Al-Ghamdi, AA; Al-Hafiz, A; Hussain, SM; Naguib, M; Panhotra, BR; Saxena, AK; Sundaram, DS; Venkateshappa, CK, 2006) |
"Gentamicin induced increase in lipid peroxides, decrease in glutathione and activities of antioxidant enzymes in the kidney, and increase in blood creatinine, and urea concentrations were significantly countered by nigerloxin treatment." | 1.40 | Fungal metabolite nigerloxin ameliorates diabetic nephropathy and gentamicin-induced renal oxidative stress in experimental rats. ( Srinivasan, K; Suresha, BS, 2014) |
" The pharmacokinetic parameters of gentamicin [volume of distribution (Vd), clearance (CL), elimination rate constant (K), and half life of elimination (t((1/2)))] were studied before hemodialysis in 20 non-diabetic patients (controls) and 20 diabetic patients, in addition to its hemodialysis clearance." | 1.35 | Pharmacokinetics of gentamicin in hemodialysis patients: a comparative study between diabetic and non-diabetic patients. ( Al-Homrany, MA; El Sherif, AK; Irshaid, YM; Omar, HA, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Suresha, BS | 1 |
Srinivasan, K | 1 |
Al-Homrany, MA | 1 |
Irshaid, YM | 1 |
El Sherif, AK | 1 |
Omar, HA | 1 |
Kiliś-Pstrusińska, K | 1 |
Saxena, AK | 1 |
Panhotra, BR | 1 |
Sundaram, DS | 1 |
Al-Hafiz, A | 1 |
Naguib, M | 1 |
Venkateshappa, CK | 1 |
Abu-Oun, BA | 1 |
Hussain, SM | 1 |
Al-Ghamdi, AA | 1 |
1 review available for gentamicin and Diabetic Glomerulosclerosis
Article | Year |
---|---|
[Carnosine, carnosinase and kidney diseases].
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Carnosine; Diabetic N | 2012 |
1 trial available for gentamicin and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placement.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; | 2006 |
2 other studies available for gentamicin and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Fungal metabolite nigerloxin ameliorates diabetic nephropathy and gentamicin-induced renal oxidative stress in experimental rats.
Topics: Aldehyde Reductase; Animals; Anti-Bacterial Agents; Aspergillus niger; Benzoates; Blood Glucose; Cre | 2014 |
Pharmacokinetics of gentamicin in hemodialysis patients: a comparative study between diabetic and non-diabetic patients.
Topics: Adult; Anti-Bacterial Agents; Diabetic Nephropathies; Female; Gentamicins; Humans; Kidney Failure, C | 2009 |